THC
Tenet Healthcare Corporation · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -11.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +1 | 64.58M | $12.09B | +9 | −7 |
| Q1 2026 | 140 | -6 | 67.35M | $12.71B | +5 | −12 |
| Q4 2025 | 146 | 0 | 74.52M | $14.80B | +2 | −1 |
| Q3 2025 | 23 | 0 | 47.80M | $9.71B | — | −1 |
| Q2 2025 | 21 | 0 | 49.65M | $8.73B | +1 | −1 |
| Q1 2025 | 18 | +1 | 24.64M | $3.31B | +1 | — |
| Q4 2024 | 17 | -2 | 22.85M | $2.89B | — | −2 |
| Q3 2024 | 18 | 0 | 21.19M | $3.52B | — | — |
| Q2 2024 | 18 | — | 23.95M | $3.19B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 7.47M | -6.9% | $1.24B | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 7.47M | -6.9% | $1.24B | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Glenview Capital ✦ | 2.66M | -43.0% | $441.89M | 9.3% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.04M | +23.6% | $339.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 2.04M | +23.6% | $339.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 1.82M | +31.7% | $301.73M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.60M | -25.2% | $265.87M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 1.60M | -10.4% | $265.61M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.08M | -31.1% | $179.14M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 740.01K | +3.6% | $122.99M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 740.01K | +3.6% | $122.99M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 721.76K | +111.5% | $117.01M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 721.76K | +111.5% | $117.01M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 721.76K | +111.5% | $117.01M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 442.95K | +31.7% | $73.62M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 309.01K | +3.1% | $51.36M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 17 | Greenlight Capital (DME Capital) ✦ | 287.10K | -52.0% | $47.72M | 2.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Greenlight Capital (DME Capital) ✦ | 287.10K | -52.0% | $47.72M | 2.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 125.12K | +29.5% | $20.80M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 110.21K | +654.9% | $18.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 72.20K | -16.8% | $12.00M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 64.58K | -68.7% | $10.73M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 49.07K | +5.5% | $8.16M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 49.07K | +5.5% | $8.16M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Harris Associates (Oakmark) ✦ | 3.90K | 0.0% | $648,180 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 686 holders, 81.68M shares, $13.63B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 2.50K sh · $652,075
Director · 4.92K sh · $1.30M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology